Quality and Outcome Measurements of Urological Patients
Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Feb 16, 2021
Trial Information
Current as of November 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Quality and Outcome Measurements of Urological Patients," is designed to gather and analyze information from patients with urologic diseases, including those with cancer related to the urinary system. The goal is to create a comprehensive database that helps researchers understand patient outcomes better and improve future treatments. The trial is currently recruiting participants aged 65 and older, and it welcomes all genders.
To take part in this study, patients must be treated at the participating locations and give their permission to have their medical history recorded. Those who choose not to provide consent will not be able to participate. If you join the trial, you can expect to have your health information collected and analyzed, which could ultimately help in enhancing care for urologic patients. Overall, this study aims to make a positive impact on the treatment and management of urologic diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients treated at the study sites, signed informed consent
- Exclusion Criteria:
- • No consent to record medical history
About Insel Gruppe Ag, University Hospital Bern
Insel Gruppe AG, the umbrella organization for the University Hospital Bern, is a leading healthcare provider in Switzerland, renowned for its commitment to advancing medical research and patient care. As a key player in clinical trials, Insel Gruppe AG integrates cutting-edge scientific inquiry with clinical excellence, facilitating innovative studies that span a wide range of medical disciplines. The institution prioritizes collaboration with academic partners and industry stakeholders to enhance the understanding of diseases and develop effective treatment options, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Biel, Switzerland
Biel, Switzerland
Patients applied
Trial Officials
Roland Seiler, Prof.
Study Chair
Department of Urology, University Hospital Bern
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials